Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company has fast-tracked the marketing and distribution of the CE-marked (EU-Class 1) Scalene Hypercharge Corona Canon (SHYCOCAN®) under “US FDA ‘Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers during the Coronavirus Disease 2019 (COVID-19) Public Health Emergency” by establishing collaborative marketing and distribution pipelines within…
Shreis Establishes Marketing and Distribution Collaborations in the US, Latin America, Mexico, and Canada for the SHYCOCAN® – A UV and Ozone-free Device that Disables Coronaviruses
More from ProductMore posts in Product »
- US Patent Issued 2025 – US 12329865 B2 “Self-sanitizing system for vehicle cabins”
- US Patent Issued 2025 – US 12329867 B2 “Methods and systems for treatment of vehicle surfaces and air”
- US Patent Application – US 20250197926 A1 “SYSTEM FOR DISINFECTING TEXTILES IN A HOUSEHOLD APPLIANCE
- Self-Contained Dianostic Tool “H3 Health Cube”Now Active In Market
- US Patent Application – US 20250186638 A1 “Method and Technique for the Focusing of UVC Light Energy to a Focused Energy Beam”